Head and Neck Carcinoma Clinical Trials & Research at Providence Medical Group
Head and neck cancers start in the tissues and organs of the head and neck
and include cancers of the larynx (voice box), throat, lips, mouth, nose,
and salivary glands. Most head and neck cancers are squamous cell carcinomas
and begin in the moist tissues that line the mouth, nose and throat. Tobacco
use, heavy alcohol use, and infection with the human papillomavirus (HPV)
increase your risk of head and neck cancer.
Providence Medical Group is currently enrolling patients for the following
head and neck carcinoma clinical trial:
A study for patients with head and neck recurrent or metastatic cancer
of the oropharynx, oral cavity, hypopharynx, and larynx
Treatment agent: Magrolimab
Physician:
Ian Anderson, MD
Study Coordinator: Melissa Ulrich //
melissa.ulrich@providence.org // 707-521-3830
Study Resources:
Study of Magrolimab Combination Therapy in Patients With Head and Neck
Squamous Cell Carcinoma - Full Text View - ClinicalTrials.gov
Sponsor: Gilead Sciences
Location: Providence Cancer Center Santa Rosa, CA